Innovating Works

EXPLORA

Desconocido
DESTINATION: AI enabled RNA nanotechnology DElivery SysTem for INformATION transfer into cells. EXPLORA SRL participó en un H2020: H2020-FETOPEN-2018-2020 By combining the interdisciplinary fields of AI/machine learning with RNA nanotechnology, biochemistry and advanced imaging methods, DESTINA...
2021-01-20 - 2025-03-31 | Financiado
Synbio4Arch: Synthetic Biology for Architecture EXPLORA SRL tramitó un H2020: H2020-FETOPEN-2018-2020 Synbio4Arch intends to leverage the foreground generated in the FET project LIAR to develop a synthetic biology toolkit for architecture. Th...
2020-05-11 - 2021-08-31 | Financiado
MIAMi: Refactoring monoterpenoid indole alkaloid production in microbial cell factories EXPLORA SRL participó en un H2020: H2020-NMBP-TR-IND-2018-2020 Plants produce some of the most potent human therapeutics and have been used for millennia to treat illnesses. The monoterpenoid indole alka...
2018-12-12 - 2023-06-30 | Financiado
SynBio4Flav: Synthetic microbial consortia based platform for flavonoids production using synthetic biology EXPLORA SRL participó en un H2020: H2020-NMBP-TR-IND-2018-2020 This Project pursues the implementation a standardized pipeline for surrogate production of plant flavonoids in synthetic microbial consorti...
2018-12-12 - 2023-08-31 | Financiado
ACDC: Artificial Cells with Distributed Cores to Decipher Protein Function EXPLORA SRL participó en un H2020: H2020-FETPROACT-2018-2020 We envision a future where ‘chemical apps’ on mobile devices produce on demand valuable compounds for health and performance as well as apps...
2018-10-23 - 2023-07-31 | Financiado
BioRoboost: Fostering Synthetic Biology standardisation through international collaboration EXPLORA SRL participó en un H2020: H2020-NMBP-TR-IND-2018-2020 Synthetic Biology is an engineering research field aiming at (re)designing biological circuits for applied purposes. As any other engineerin...
2018-09-27 - 2021-09-30 | Financiado
DELIVER: DELIVERy of advanced therapies for diabetes training network EXPLORA SRL participó en un H2020: H2020-MSCA-ITN-2018 The DELIVER EID programme aims to equip 6 industrial PhD graduates with all of the tools required to become creative, entrepreneurial and in...
2018-08-20 - 2022-12-31 | Financiado
TOPCAPI: Thoroughly Optimised Production Chassis for Advanced Pharmaceutical Ingredients EXPLORA SRL participó en un H2020: H2020-NMBP-2016-2017 TOPCAPI will exploit the natural fabrication power of actinomycetes as microbial cell factories to produce three high value compounds: GE227...
2016-11-09 - 2021-09-30 | Financiado
LIAR: Living Architecture EXPLORA SRL participó en un H2020: H2020-FETOPEN-2014-2015 Living Architecture (LIAR) is a modular bioreactor-wall, which is based on the operational principles of microbial fuel cell technology and...
2015-11-17 - 2019-06-30 | Financiado
DRIVE: Diabetes Reversing Implants with enhanced Viability and long term Efficacy EXPLORA SRL participó en un H2020: H2020-NMP-2014-2015 Diabetes mellitus is a chronic disease characterised by high blood glucose due to inadequate insulin production and/or insulin resistance wh...
2015-05-13 - 2019-05-31 | Financiado
THE GRAIL: Tissue in Host Engineering Guided Regeneration of Arterial Intimal Layer EXPLORA SRL tramitó un FP7: "The concept of THE GRAIL project is the creation of an in vivo, in situ structured bioactive, selectively porous, bioresorbable scaffold th...
Financiado
AMCARE: Advanced Materials for Cardiac Regeneration AMCARE EXPLORA SRL participó en un FP7: The Advanced Materials for Cardiac Regeneration (AMCARE) consortium aims to establish a translational research program to develop truly rest...
Financiado
MAGISTER: Magnetic Scaffolds for in vivo Tissue Engineering EXPLORA SRL participó en un FP7: The main driving idea of the project is the creation of conceptually new type of scaffolds able to be manipulated in situ by means of magnet...
Financiado
NEXT: Nano Engineering for Cross Tolerance new approach for bioengineered vascularised chimeric islet t... EXPLORA SRL participó en un FP7: Diabetes is caused by insufficient or lack of insulin secretion by the specialized B cells of the pancreas and, if not treated adequately ev...
Financiado
ETOILE: BIOETHANOL PRODUCTION VIA LIGNOCELLULOSIC FERMENTATION OF OLIVE OIL RESIDUES Bioethanol has been increasingly becoming the renewable energy source that could reduce the oil dependence of the developed countries. Biore...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.